PRICE T ROWE ASSOCIATES INC /MD/ - SPECTRUM PHARMACEUTICALS INC ownership

SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 142 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 11.38 and the average weighting 0.0%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of SPECTRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$28
+27.3%
28,3050.0%0.00%
Q1 2023$22
+69.2%
28,305
-18.5%
0.00%
Q4 2022$13
-99.9%
34,751
-1.7%
0.00%
Q3 2022$16,000
-50.0%
35,352
-13.7%
0.00%
Q2 2022$32,000
-54.9%
40,948
-25.6%
0.00%
Q1 2022$71,000
+14.5%
55,026
+13.1%
0.00%
Q4 2021$62,000
-73.8%
48,651
-55.3%
0.00%
Q3 2021$237,000
-51.4%
108,904
-16.3%
0.00%
Q2 2021$488,000
+19.0%
130,104
+3.5%
0.00%
Q1 2021$410,000
-2.4%
125,692
+2.0%
0.00%
Q4 2020$420,000
-20.6%
123,251
-4.9%
0.00%
Q3 2020$529,000
+11.8%
129,648
-7.4%
0.00%
Q2 2020$473,000
+50.6%
139,947
+3.9%
0.00%
Q1 2020$314,000
+61.0%
134,638
+151.5%
0.00%
Q4 2019$195,000
-56.0%
53,527
+0.2%
0.00%
Q3 2019$443,000
-0.7%
53,408
+3.1%
0.00%
Q2 2019$446,000
-18.6%
51,791
+0.9%
0.00%
Q1 2019$548,000
+23.7%
51,305
+1.2%
0.00%
Q4 2018$443,000
+19.7%
50,674
+130.3%
0.00%
Q3 2018$370,000
-17.0%
22,003
+3.3%
0.00%
Q2 2018$446,000
+53.8%
21,300
+18.2%
0.00%
Q1 2018$290,000
-13.4%
18,015
+1.9%
0.00%
Q4 2017$335,000
-8.5%
17,686
-32.0%
0.00%
Q3 2017$366,000
+88.7%
26,0160.0%0.00%
Q2 2017$194,000
+9.6%
26,016
-4.4%
0.00%
Q1 2017$177,000
+47.5%
27,2000.0%0.00%
Q4 2016$120,000
-5.5%
27,2000.0%0.00%
Q3 2016$127,000
-29.1%
27,2000.0%0.00%
Q2 2016$179,000
+3.5%
27,2000.0%0.00%
Q1 2016$173,000
+5.5%
27,2000.0%0.00%
Q4 2015$164,00027,2000.00%
Other shareholders
SPECTRUM PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Consonance Capital Management LP 2,020,583$15,053,0001.77%
Piermont Capital Management Inc. 247,882$1,847,0000.53%
BARD ASSOCIATES INC 129,380$964,0000.44%
Sonora Investment Management, LLC 239,202$1,782,055,0000.34%
TFS CAPITAL LLC 97,526$727,0000.28%
Alambic Investment Management, L.P. 165,001$1,229,0000.15%
KENNEDY CAPITAL MANAGEMENT LLC 491,075$3,659,0000.07%
Renaissance Technologies 6,071,817$45,235,0000.06%
Granite Investment Partners, LLC 97,023$723,0000.05%
ClariVest Asset Management LLC 241,909$1,802,0000.04%
View complete list of SPECTRUM PHARMACEUTICALS INC shareholders